| Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody MK Robinson, M Doss, C Shaller, D Narayanan, JD Marks, LP Adler, ... Cancer Research 65 (4), 1471-1478, 2005 | 206 | 2005 |
| The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma A Konski, M Doss, B Milestone, O Haluszka, A Hanlon, G Freedman, ... International Journal of Radiation Oncology* Biology* Physics 61 (4), 1123-1128, 2005 | 189 | 2005 |
| Linear no-threshold model vs. radiation hormesis M Doss Dose-response 11 (4), dose-response. 13-005. Doss, 2013 | 157 | 2013 |
| Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans M Doss, HC Kolb, JJ Zhang, MJ Bélanger, JB Stubbs, MG Stabin, ... Journal of Nuclear Medicine 53 (5), 787-795, 2012 | 109 | 2012 |
| Positron emission mammography: initial clinical results EA Levine, RI Freimanis, ND Perrier, K Morton, NM Lesko, S Bergman, ... Annals of Surgical Oncology 10, 86-91, 2003 | 109 | 2003 |
| Characterization of the normal adrenal gland with 18F-FDG PET/CT B Bagheri, AH Maurer, L Cone, M Doss, L Adler Journal of Nuclear Medicine 45 (8), 1340-1343, 2004 | 98 | 2004 |
| 90Y ‐PET imaging: Exploring limitations and accuracy under conditions of low counts and high random fraction T Carlier, KP Willowson, E Fourkal, DL Bailey, M Doss, M Conti Medical physics 42 (7), 4295-4309, 2015 | 72 | 2015 |
| The risk of cancer from CT scans and other sources of low-dose radiation: a critical appraisal of methodologic quality CH Schultz, R Fairley, LSL Murphy, M Doss Prehospital and disaster medicine 35 (1), 3-16, 2020 | 70 | 2020 |
| Are we approaching the end of the linear no-threshold era? M Doss Journal of Nuclear Medicine 59 (12), 1786-1793, 2018 | 69 | 2018 |
| Biodistribution and radiation dosimetry of the hypoxia marker 18F–HX4 in monkeys and humans determined by using whole-body PET/CT M Doss, JJ Zhang, MJ Bélanger, JB Stubbs, ED Hostetler, K Alpaugh, ... Nuclear medicine communications 31 (12), 1016-1024, 2010 | 66 | 2010 |
| Quantitation of small-animal 124I activity distributions using a clinical PET/CT scanner DEG Trotter, RM Manjeshwar, M Doss, C Shaller, MK Robinson, ... Journal of Nuclear Medicine 45 (7), 1237-1244, 2004 | 60 | 2004 |
| Evidence supporting radiation hormesis in atomic bomb survivor cancer mortality data M Doss Dose-response 10 (4), dose-response. 12-023. Doss, 2012 | 54 | 2012 |
| Evaluation of the anti-HER2 C6. 5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment S Reddy, CC Shaller, M Doss, I Shchaveleva, JD Marks, JQ Yu, ... Clinical Cancer Research 17 (6), 1509-1520, 2011 | 49 | 2011 |
| Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers M Doss, HC Kolb, JC Walsh, V Mocharla, H Fan, A Chaudhary, Z Zhu, ... Journal of Nuclear Medicine 54 (12), 2087-2092, 2013 | 45 | 2013 |
| Elastic Scattering of 50-MeV π+ from C 12 JF Amann, PD Barnes, M Doss, SA Dytman, RA Eisenstein, ... Physical Review Letters 35 (7), 426, 1975 | 44 | 1975 |
| Point/counterpoint: low-dose radiation is beneficial, not harmful M Doss, MP Little, CG Orton Medical physics 41 (7), 2014 | 43 | 2014 |
| Shifting the paradigm in radiation safety M Doss Dose-response 10 (4), dose-response. 11-056. Doss, 2012 | 38 | 2012 |
| Commentary: ethical issues of current health-protection policies on low-dose ionizing radiation Y Socol, L Dobrzyński, M Doss, F Ludwig E, MK Janiak, ML Miller, ... Dose-Response 12 (2), dose-response. 13-044. Socol, 2014 | 36 | 2014 |
| Low dose radiation adaptive protection to control neurodegenerative diseases M Doss Dose-response 12 (2), dose-response. 13-030. Doss, 2014 | 34 | 2014 |
| A critical assessment of the linear no-threshold hypothesis: its validity and applicability for use in risk assessment and radiation protection JA Siegel, AL Brooks, DR Fisher, PB Zanzonico, M Doss, MK O'Connor, ... Clinical nuclear medicine 44 (7), 521-525, 2019 | 32 | 2019 |
